Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 8, 2010

Premium

Integrated Diagnostics announced this week that Gregory Critchfield has joined the company's board as an independent director.

Critchfield is the former president of Myriad Genetic Laboratories and recently served as an independent director at molecular biological tools company BioTrove.


Ian Pike was appointed this week to Proteome Sciences' board of directors.

Pike joined the company in 2002 and is currently its chief operating officer. Prior to that, he worked for Wellcome, Murex Biotech, and Abbott-Murex.


Caprotec this week appointed Rainer Metternich managing director, chief business officer, and chief operating officer.

Prior to joining Caprotec, Metternich held senior positions at Merck, Schering, and Novartis.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.